Crewe Advisors LLC Amgen Inc Transaction History

Crewe Advisors LLC

$888 Million
Q2 2024

A detailed history of Crewe Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Crewe Advisors LLC holds 1,446 shares of AMGN stock, worth $456,936. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,446

Previous 1,485 2.63%

Holding current value

$456,936

Previous $422,000 6.87%

% of portfolio

0.05%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$262.75 - $319.31 $10,247 - $12,453	-39 Reduced 2.63%	1,446 $451,000
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $399,271 - $481,971	1,485 New	1,485 $422,000
Q2 2023 Jul 28, 2023	SELL	$214.27 - $253.37 $3,428 - $4,053	-16 Reduced 1.24%	1,279 $283,000
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $10,160 - $12,384	-45 Reduced 3.36%	1,295 $313,000
Q4 2022 Feb 07, 2023	BUY	$229.03 - $291.01 $159,862 - $203,124	698 Added 108.72%	1,340 $351,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $11,896 - $13,416	-53 Reduced 7.63%	642 $145,000
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $33,683 - $37,484	146 Added 26.59%	695 $169,000
Q1 2022 Apr 27, 2022	BUY	$219.27 - $242.57 $72,139 - $79,805	329 Added 149.55%	549 $133,000
Q4 2020 Jan 27, 2021	SELL	$216.38 - $257.67 $16,012 - $19,067	-74 Reduced 25.17%	220 $51,000
Q3 2020 Oct 13, 2020	BUY	$234.65 - $260.95 $17,364 - $19,310	74 Added 33.64%	294 $75,000
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $4,178 - $5,006	-24 Reduced 9.84%	220 $43,000
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $3,667 - $4,299	22 Added 9.91%	244 $45,000
Q1 2019 May 10, 2019	BUY	$180.87 - $203.88 $361 - $407	2 Added 0.91%	222 $42,000
Q2 2018 Aug 07, 2018	SELL	$166.05 - $186.51 $22,914 - $25,738	-138 Reduced 38.55%	220 $41,000
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $8,979 - $10,494	53 Added 17.38%	358 $61,000
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $51,480 - $57,519	305	305 $53,000

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.

Account

Crewe Advisors LLC Amgen Inc Transaction History